MEDVi vs MyStart Health: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
MEDVi and MyStart Health are tied at 7.7/10. MyStart Health is more affordable at $249/mo vs $299/mo. Choose MEDVi for users who want a low entry price with oral and injectable co. Choose MyStart Health for users who value a money-back weight-loss guarantee and price.
A side-by-side comparison of MEDVi and MyStart Health covering pricing, scores, medication types, insurance, and more to help you decide.
MEDVi
#21 of 40Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.
Visit MEDViMyStart Health
#20 of 40GLP-1 provider offering a unique money-back guarantee and price-lock protection for long-term cost certainty.
Visit MyStart Health| Feature | MEDVi | MyStart Health |
|---|---|---|
| Our Score | 7.7/10 | 7.7/10 |
| Starting Price | $299/mo | $249/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Users who want a low entry price with oral and injectable compounded options | Users who value a money-back weight-loss guarantee and price-lock protection |
| Ranking | #21 | #20 |
Pros & Cons Compared
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
MyStart Health
Pros
- +Price Lock Guarantee ensures your monthly rate never increases even as your GLP-1 dose escalates — a genuine differentiator
- +Access to 600+ board-certified doctors with unlimited clinician messaging at no additional cost
- +Competitive pricing at $149-$179/mo for compounded semaglutide with free shipping included
- +HSA/FSA eligible — can use pre-tax health savings to pay for treatment
Cons
- −Cash-pay only — no insurance accepted, which limits options for patients with GLP-1 coverage
- −Only available in select states — not all 50, and the exact state list isn't published
- −Compounded medications only — no brand-name GLP-1 options available
Our Verdict
MEDVi and MyStart Health are closely matched with identical scores of 7.7/10. If budget is your priority, MyStart Health starts at $249/mo compared to MEDVi's $299/mo. MyStart Health offers both brand-name and compounded medications, giving you more flexibility. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options. Choose MyStart Health if you want: users who value a money-back weight-loss guarantee and price-lock protection.